Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

NCT01814813 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

90

Enrollment

OTHER

Sponsor class

Stopped DSMB futility analysis

Conditions

Recurrent Glioblastoma
Recurrent Adult Brain Tumor
Gliosarcoma

Interventions

BIOLOGICAL: HSPPC-96
DRUG: bevacizumab

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]